Similar articles for PMID: 31044463

Year	Number of Results
1992	1
1993	1
1994	1
2002	1
2005	1
2006	1
2007	3
2008	7
2009	8
2010	4
2011	6
2012	7
2013	7
2014	6
2015	9
2016	10
2017	9
2018	10
2019	8
2020	2
2021	2
2022	4
2023	1
2024	0

1

Low- and high-dose aripiprazole augmentation and plasma levels of homovanillic acid in major depressive disorder: A randomized, open-label study.

Horikoshi S, Miura I, Ichinose M, Yamamoto S, Ito M, Watanabe K, Kanno-Nozaki K, Kaneko H, Yabe H. Horikoshi S, et al. Hum Psychopharmacol. 2019 May;34(3):e2696. doi: 10.1002/hup.2696. Epub 2019 May 1. Hum Psychopharmacol. 2019. PMID: 31044463 Clinical Trial.

2

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN. Berman RM, et al. CNS Spectr. 2009 Apr;14(4):197-206. doi: 10.1017/s1092852900020216. CNS Spectr. 2009. PMID: 19407731 Clinical Trial.

3

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.

Han C, Wang SM, Kwak KP, Won WY, Lee H, Chang CM, Tang TC, Pae CU. Han C, et al. J Psychiatr Res. 2015 Jul-Aug;66-67:84-94. doi: 10.1016/j.jpsychires.2015.04.020. Epub 2015 May 5. J Psychiatr Res. 2015. PMID: 26013203 Clinical Trial.

4

Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.

Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, Leri F, McInerney S, MacQueen GM, Minuzzi L, Müller DJ, Parikh SV, Placenza FM, Quilty LC, Ravindran AV, Sassi RB, Soares CN, Strother SC, Turecki G, Vaccarino AL, Vila-Rodriguez F, Yu J, Uher R; CAN-BIND Investigator Team. Kennedy SH, et al. J Clin Psychiatry. 2019 Feb 5;80(2):18m12202. doi: 10.4088/JCP.18m12202. J Clin Psychiatry. 2019. PMID: 30840787 Clinical Trial.

5

Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.

Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M. Mischoulon D, et al. J Clin Psychiatry. 2012 Mar;73(3):353-7. doi: 10.4088/JCP.10m06541. Epub 2011 Sep 20. J Clin Psychiatry. 2012. PMID: 21939613 Clinical Trial.

6

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM. Marcus RN, et al. J Clin Psychopharmacol. 2008 Apr;28(2):156-65. doi: 10.1097/JCP.0b013e31816774f9. J Clin Psychopharmacol. 2008. PMID: 18344725 Clinical Trial.

7

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.

Nelson JC, Thase ME, Bellocchio EE, Rollin LM, Eudicone JM, McQuade RD, Marcus RN, Berman RM, Baker RA. Nelson JC, et al. Int Clin Psychopharmacol. 2012 May;27(3):125-33. doi: 10.1097/YIC.0b013e3283502791. Int Clin Psychopharmacol. 2012. PMID: 22466058

8

Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: a randomized, double-blind, placebo-controlled study (ADMIRE study).

Kamijima K, Higuchi T, Ishigooka J, Ohmori T, Ozaki N, Kanba S, Kinoshita T, Koyama T; ADMIRE Study Group. Kamijima K, et al. J Affect Disord. 2013 Dec;151(3):899-905. doi: 10.1016/j.jad.2013.07.035. Epub 2013 Aug 28. J Affect Disord. 2013. PMID: 24074484 Free article. Clinical Trial.

9

Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study.

Jon DI, Kim DH, Seo HJ, Kwon YJ, Kim MD, Yang JC, Suh HS, Min KJ, Pae CU, Bahk WM. Jon DI, et al. Clin Neuropharmacol. 2013 Sep-Oct;36(5):157-61. doi: 10.1097/WNF.0b013e3182a31f3d. Clin Neuropharmacol. 2013. PMID: 24045606 Clinical Trial.

10

Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.

Simon JS, Nemeroff CB. Simon JS, et al. J Clin Psychiatry. 2005 Oct;66(10):1216-20. doi: 10.4088/jcp.v66n1002. J Clin Psychiatry. 2005. PMID: 16259533 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year